New Legal Pathway for Biosimilars Creates Opportunities and Challenges For Biological Manufacturers — A Guide To The Legislation
June 14, 2010
Foley Partners Jacqueline Wright Bonilla and Nathan Beaver authored an article that appeared in the June 2010 issue of Bloomberg’s Health Law Report titled “New Legal Pathway for Biosimilars Creates Opportunities and Challenges For Biological Manufacturers — A Guide To The Legislation.”
Author(s)
Related Insights
December 23, 2025
Foley Viewpoints
The Rush to Exit: PE Firms Pick Up the Pace in 2025
Key Points: PE firms are moving to sell portfolio companies on an accelerated timeline in 2025 after years of much longer hold…
December 22, 2025
Labor & Employment Law Perspectives
‘Tis the Season
‘Tis the Season… You probably do not think of HR compliance when you hear the phrase. But the end of 2025 is a good time — even in the…
January 27, 2026
Events
Fashion Law 2025 Year in Review
In 2025, the fashion industry faced significant challenges and opportunities driven by geopolitical shifts, rising tariffs and trade policy changes, and evolving consumer expectations, while innovation in brand protection and strategic partnerships supported resilience and growth.